| Date |
Research Question / Title |
Unique ID |
Research Team |
|
March 3, 2021
|
What is the risk of COVID-19 acquisition via exposures of the ocular mucosa?
|
PPE030101-01 ESR
|
Personal Protective Equipment
|
|
December 18, 2020
|
What is the risk of COVID-19 transmission during AGMP procedures?
|
PPE120901 RR
|
Personal Protective Equipment
|
|
December 11, 2020
|
What is the risk of COVID-19 transmission during AGMP procedures?
|
PPE120901-01 ESR
|
Personal Protective Equipment
|
|
November 20, 2020
|
What evidence is available regarding degradation of N95 respirators/masks?
|
PPE110203 RR
|
Personal Protective Equipment
|
|
November 20, 2020
|
What is the evidence to support the reprocessing and re-use of N95 respirators by healthcare workers?
|
PPE110201 RR
|
Personal Protective Equipment
|
|
November 10, 2020
|
What evidence is available regarding degradation of N95 respirators/masks?
|
PPE110203-01 ESR
|
Personal Protective Equipment
|
|
November 6, 2020
|
What is the evidence to support the reprocessing and re-use of N95 respirators by healthcare workers?
|
PPE110201-01 ESR
|
Personal Protective Equipment
|
|
April 17, 2020
|
What distinguishes COVID-19 from influenza-like illnesses?
|
PPE041701 RR
|
Personal Protective Equipment
|
|
April 17, 2020
|
What distinguishes COVID-19 from influenza-like illnesses?
|
PPE041701-01 ESR
|
Personal Protective Equipment
|
|
April 17, 2020
|
What is the clinical evidence used to support aerosol generating medical procedures recommendations and guidelines regarding line flow volume or pressure?
|
PPE041702-01 ESR
|
Personal Protective Equipment
|
